Japan And Other OECD Nations To Accept Pre-clinical Data From Singapore
This article was originally published in PharmAsia News
Executive Summary
Singapore's Standards, Productivity and Innovation Board announced Oct. 29 pre-clinical research data, in vitro and in vivo, from good laboratory practice-compliant companies in Singapore will be accepted in any of the 30 Organization for Economic Cooperation and Development countries, including Japan, the U.S. and EU